Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Astellas Institute for Regenerative Medicine Relocation

Project Type

Research and development facility


Massachusetts, US

Estimated Investment

¥14bn ($124m)

Start of Construction

September 2018

Expected Completion

January 2020

Owner /Developer

Astellas Pharma

Go Top